Nanoparticle-based approaches to target the lymphatic system for antitumor treatment
- PMID: 33963442
- PMCID: PMC11072902
- DOI: 10.1007/s00018-021-03842-6
Nanoparticle-based approaches to target the lymphatic system for antitumor treatment
Abstract
Immunotherapies have been established as safe and efficient modalities for numerous tumor treatments. The lymphatic system, which is an important system, can modulate the immune system via a complex network, which includes lymph nodes, vessels, and lymphocytes. With the deepening understanding of tumor immunology, a plethora of immunotherapies, which include vaccines, photothermal therapy, and photodynamic therapy, have been established for antitumor treatments. However, the deleterious off-target effects and nonspecific targeting of therapeutic agents result in low efficacy of immunotherapy. Fortunately, nanoparticle-based approaches for targeting the lymphatic system afford a unique opportunity to manufacture drugs that can simultaneously tackle both aspects, thereby improving tumor treatments. Over the past decades, great strides have been made in the development of DC vaccines and nanomedicine as antitumor treatments in the field of lymphatic therapeutics and diagnosis. In this review, we summarize the current strategies through which nanoparticle technology has been designed to target the lymphatic system and describe applications of lymphatic imaging for the diagnosis and image-guided surgery of tumor metastasis. Moreover, improvements in the tumor specificity of nanovaccines and medicines, which have been realized through targeting or stimulating the lymphatic system, can provide amplified antitumor immune responses and reduce side effects, thereby promoting the paradigm of antitumor treatment into the clinic to benefit patients.
Keywords: Combinational immunotherapy; DC vaccine; Image-guided therapy; Lymphatic targeting; Lymphoscintigraphy; Nanoplatform; Tumor metastasis.
Figures


Similar articles
-
Nanoparticle-based immunotherapy for cancer.ACS Nano. 2015 Jan 27;9(1):16-30. doi: 10.1021/nn5062029. Epub 2014 Dec 23. ACS Nano. 2015. PMID: 25469470 Review.
-
Nanoparticle mediated cancer immunotherapy.Semin Cancer Biol. 2021 Feb;69:307-324. doi: 10.1016/j.semcancer.2020.03.015. Epub 2020 Apr 4. Semin Cancer Biol. 2021. PMID: 32259643 Review.
-
A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery.J Nanobiotechnology. 2021 Dec 20;19(1):432. doi: 10.1186/s12951-021-01186-8. J Nanobiotechnology. 2021. PMID: 34930301 Free PMC article.
-
Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.Acc Chem Res. 2020 Oct 20;53(10):2094-2105. doi: 10.1021/acs.accounts.0c00456. Epub 2020 Oct 5. Acc Chem Res. 2020. PMID: 33017150 Free PMC article.
-
Impact of nanoparticle properties on immune cell interactions in the lymph node.Acta Biomater. 2025 Jan 24;193:65-82. doi: 10.1016/j.actbio.2024.12.039. Epub 2024 Dec 17. Acta Biomater. 2025. PMID: 39701340 Review.
Cited by
-
Multifunctional Gold Nanoclusters for Effective Targeting, Near-Infrared Fluorescence Imaging, Diagnosis, and Treatment of Cancer Lymphatic Metastasis.ACS Nano. 2022 Oct 25;16(10):16019-16037. doi: 10.1021/acsnano.2c03752. Epub 2022 Sep 21. ACS Nano. 2022. PMID: 36130729 Free PMC article.
-
Hyaluronic acid modified indocyanine green nanoparticles: a novel targeted strategy for NIR-II fluorescence lymphatic imaging.Front Chem. 2024 Jul 3;12:1435627. doi: 10.3389/fchem.2024.1435627. eCollection 2024. Front Chem. 2024. PMID: 39021390 Free PMC article.
-
The Therapeutic Effect of Second Near-Infrared Absorbing Gold Nanorods on Metastatic Lymph Nodes via Lymphatic Delivery System.Pharmaceutics. 2021 Aug 28;13(9):1359. doi: 10.3390/pharmaceutics13091359. Pharmaceutics. 2021. PMID: 34575435 Free PMC article.
-
Advances in molecular imaging and targeted therapeutics for lymph node metastasis in cancer: a comprehensive review.J Nanobiotechnology. 2024 Dec 19;22(1):783. doi: 10.1186/s12951-024-02940-4. J Nanobiotechnology. 2024. PMID: 39702277 Free PMC article. Review.
-
Cytotoxic effects of bee venom-loaded ZIF-8 nanoparticles on thyroid cancer cells: a promising strategy for targeted therapy.Med Oncol. 2024 Dec 19;42(1):32. doi: 10.1007/s12032-024-02584-2. Med Oncol. 2024. PMID: 39699709
References
-
- Ribas A. Adaptive immune resistance: how cancer protects from immune attack. Cancer Discov. 2015;5(9):915. doi: 10.1158/2159-8290.CD-15-0563. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous